Osaka University · Faculty of Medicine / Graduate School of Medical Sciences

Research keywordsWT1 cancer vaccine・cancer immunotherapy・dendritic cell vaccine・CAR-T cells・TCR avidity・cytotoxic T lymphocytes・immunoproteasome inhibition・ELISPOT monitoring・mesothelioma immunology・peptide vaccination

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.2025 · Journal for immunotherapy of cancer Vol. 13 No. 7 2025年7月31日 研究論文（学術雑誌）
• Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.2024 · PloS one Vol. 19 No. 8 2024年 研究論文（学術雑誌）
• Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumor.2024 · Cancer immunology, immunotherapy : CII Vol. 74 No. 1 p. 15-15 2024年11月7日 研究論文（学術雑誌）
• WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT12023 · Cancers Vol. 15 No. 2 p. 393-393 2023年1月6日 研究論文（学術雑誌）

• Official profile